Related Experiment Video
Updated: Aug 23, 2026

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
Published on: August 8, 2025
[Study on the molecular mechanism of quinolone resistance in Shigellae spp]
Jing-yuan Zhu1, Guang-cai Duan, Yuan-lin Xi
1The Department of Environmental Hygiene, College of Public Health, Zhengzhou University, Zhengzhou 450052, China.
Objective:
To study the resistance and its mechanism of Shigellae spp. to quinolones.
Methods:
Seventy-three clinical isolates were collected. Susceptibility tests of pipemidic adcid (PI), ofloxacin (OFL), norfloxacin (NOR), and ciprofloxacin (CIP) were performed in all clinical isolates and Shigella 51573. The N-terminal coding region of gyrA and parC were amplified by polymerase chain reaction (PCR) respectively. Restriction fragment length polymorphism (RFLP) was applied to all PCR procucts of gyrA and parC, and single strand conformational polymorphism analysis (SSCP) was also applied to PCR procucts of parC.
Results:
The resistance rates for all the Shigella spp. to PI, CIP, NOR and OFL were 79.5%, 60.3%, 41.1% and 36.9%. Sixty-seven strains (91.8%) were quinolone-reduced-sensitive isolates, in which 61 strains (91%) were found carrying mutations in gyrA with 5 strains (7.5%) found carrying mutations in parC. No mutation was found in 6 quinolone-sensitive isolates or Shigella 51573.
Conclusion:
The Shigella spp. had high resistance rates to quinolones. The target gene mutations which were mainly found in gyrA and secondarily in parC, played an important role in the quinolone-resistance in Shigella spp.
Insights
Shigella species exhibit high resistance to quinolones, primarily due to mutations in the gyrA gene, and secondarily in the parC gene. This study investigated the resistance mechanisms in clinical Shigella isolates.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Context:
- Quinolone antibiotics are crucial for treating bacterial infections.
- Shigella species are significant human pathogens.
- Understanding antimicrobial resistance is vital for public health.
Purpose:
- To investigate the quinolone resistance and its underlying mechanisms in Shigella species.
- To determine the prevalence of mutations in gyrA and parC genes associated with quinolone resistance.
Summary:
- This study analyzed 73 clinical Shigella isolates for their susceptibility to pipemidic acid, ciprofloxacin, norfloxacin, and ofloxacin.
- High resistance rates were observed. Mutations in gyrA were found in 91% of resistant isolates, with parC mutations in 7.5%.
Impact:
- The findings highlight the significant role of target gene mutations, particularly in gyrA, in conferring quinolone resistance in Shigella.
- This research provides critical insights for developing effective treatment strategies against Shigella infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance

